AstraZeneca
Fusion Pharmaceuticals, part of AstraZeneca, is a clinical-stage oncology company specializing in developing radioconjugates as precision medicines. The company operates a GMP-compliant radiopharmaceutical manufacturing facility and focuses on advancing its portfolio of targeted cancer therapies.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Director, Global Patient Safety Science
Revolution Medicines
Senior Oncology Account Manager – Detroit, MI
Revolution Medicines
Scientist - Radiochemistry
American Association of Physicists in Medicine
Territory Account Manager - Phoenix
Telix Pharmaceuticals
Senior Oncology Account Manager – Kansas City, KS
Revolution Medicines
Senior Oncology Account Manager – Lansing, MI
Revolution Medicines